ORG Wealth Partners LLC Decreases Stock Holdings in The Procter & Gamble Company (NYSE:PG)

ORG Wealth Partners LLC cut its stake in The Procter & Gamble Company (NYSE:PG) by 40.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,806 shares of the company’s stock after selling 1,900 shares during the period. ORG Wealth Partners LLC’s holdings in Procter & Gamble were worth $471,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the second quarter worth $29,000. RPg Family Wealth Advisory LLC purchased a new stake in Procter & Gamble during the third quarter worth $33,000. Quest Partners LLC purchased a new stake in Procter & Gamble during the second quarter worth $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in Procter & Gamble during the second quarter worth $44,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

PG stock traded down $2.84 during trading hours on Friday, hitting $159.26. 2,729,692 shares of the stock traded hands, compared to its average volume of 5,898,862. The stock has a 50-day simple moving average of $169.77 and a 200 day simple moving average of $169.64. The Procter & Gamble Company has a one year low of $146.28 and a one year high of $180.43. The company has a market cap of $375.06 billion, a P/E ratio of 27.46, a P/E/G ratio of 3.70 and a beta of 0.45. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter last year, the business posted $1.83 earnings per share. The company’s quarterly revenue was down .6% on a year-over-year basis. Equities analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target for the company. Evercore ISI boosted their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Finally, Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $179.75.

Insider Buying and Selling

In other news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at $2,343,110. This trade represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,439 shares of company stock valued at $13,317,460. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.